Oribel Capital Management’s Bio-Techne TECH Stock Holding History

Oribel Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-211,400	Closed	-$12.4M	–	175
2025 Q4	$12.4M	Buy	+211,400	New	+$12.8M	0.57%	56

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oribel Capital Management's TECH Position: Q2 2024 in Review

Oribel Capital Management sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 71,400 shares — an estimated $5.03M sold.

Oribel Capital Management first reported a position in TECH in Q4 2023 and held it in 2 quarters. The position peaked at $9.01M in Q4 2023. 571 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

Oribel Capital Management reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
Oribel Capital Management sold 71,400 Bio-Techne shares in Q2 2024, an estimated $5.03M.
Oribel Capital Management first reported a position in Bio-Techne in Q4 2023 and held it in 2 quarters.
Oribel Capital Management's Bio-Techne position peaked at $9.01M in Q4 2023.
571 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Oribel Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.